Peptide 'cheatsheets' on TikTok: what the gym crowd gets wrong

What's this video probably claiming?

A "peptide cheatsheet" from a gymtok creator almost certainly runs through a curated list of bioactive peptides, probably BPC-157, TB-500, CJC-1295, ipamorelin, and possibly GHK-Cu or MK-677, and assigns each one a clean, digestible function. Think: "BPC-157 heals tendons," "CJC-1295 plus ipamorelin spikes growth hormone," "TB-500 accelerates recovery." These videos follow a recognizable format: bullet-point claims, confident delivery, no citations, and implicit framing that these compounds are safe tools any serious gym-goer should know about. The creator handle references "biosync labs" and an EU suffix, which typically signals a grey-market supplier or affiliated promoter. That context matters. When a vendor-adjacent account publishes a "cheatsheet," the educational framing is rarely neutral.

What does the science actually show?

The honest answer is: less than TikTok implies, and the data quality varies wildly by peptide. BPC-157 has shown tendon and gut healing effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but zero completed randomized controlled trials in humans. TB-500, or its active fragment Ac-SDKP, has cardioprotective signals in animal studies (Sharma et al., 2010, Pharmacological Research) but again, no human RCT data. CJC-1295 combined with ipamorelin does produce measurable GH and IGF-1 elevation in humans. Ionescu et al. (2013, Journal of Clinical Endocrinology and Metabolism) showed sustained GH pulses with modified GRF analogs, but subjects were GH-deficient adults, not healthy athletes. MK-677, technically not a peptide but often bundled in these lists, showed lean mass gains of roughly 1.6 kg over 12 months in older adults (Nass et al., 2008, Journal of Clinical Endocrinology and Metabolism), alongside meaningful edema and insulin resistance signals.

Where does the social media noise diverge from clinical reality?

Several places. First, dose extrapolation. Gym communities frequently apply doses from rodent studies directly to humans, adjusting only by body weight. This is not how pharmacokinetics work. Bioavailability, receptor density, and metabolic clearance differ fundamentally across species. Second, the "stack" mentality. Cheatsheet content implicitly normalizes combining multiple peptides simultaneously, but there are no safety studies on most of these compounds in isolation in humans, let alone in combination. Third, purity and contamination risk. A 2020 analysis by van Thuijl et al. in Drug Testing and Analysis found that a significant proportion of peptide products sold through online channels contained incorrect concentrations or undisclosed contaminants. Fourth, regulatory status is consistently omitted. BPC-157 and TB-500 are not approved by the FDA or EMA for any indication. Framing them as gym supplements obscures that reality entirely.

What should you actually know?

If you encountered this video and felt informed afterward, that is worth questioning. A genuine cheatsheet on peptides would include failure modes, not just functions. It would tell you that subcutaneous peptide injection carries infection risk without sterile technique. It would note that GH-stimulating peptides like ipamorelin and CJC-1295 are banned in competitive sport by WADA. It would be upfront that MK-677 raises fasting insulin in healthy subjects, which is a real concern for anyone with metabolic risk factors. And it would acknowledge that most peptide research currently showing promise in humans is in disease populations, not healthy athletes chasing incremental recovery gains. The "cheatsheet" format is designed to make complex, unresolved pharmacology feel settled and actionable. It is not. Anyone considering peptide therapy should have that conversation with a licensed clinician who can review their bloodwork and health history, not a six-second bullet list on TikTok.